Quantitative chemical proteomics for identifying candidate drug targets.
about
Approaches for targeted proteomics and its potential applications in neuroscienceMass spectrometry-based proteomics turns quantitativeChemical genetics for therapeutic target mining.Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents: the yeast salinity stress response.Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.A phase I and pharmacokinetic study of indisulam in combination with carboplatinProteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses.The end game of chemical genetics: target identification.Clinical proteomics of myeloid leukemia.Chemical proteomics and its impact on the drug discovery process.Target identification for small bioactive molecules: finding the needle in the haystack.Protein analysis by shotgun/bottom-up proteomicsTarget identification and mechanism of action in chemical biology and drug discovery.Surface plasmon resonance mass spectrometry in proteomics.Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.Strategies for facilitated forward chemical genetics.In-silico gene co-expression network analysis in Paracoccidioides brasiliensis with reference to haloacid dehalogenase superfamily hydrolase gene.Toxicoproteomics: proteomics applied to toxicology and pathology.Phase II study of E7070 in patients with metastatic melanoma.Advances in protein complex analysis using mass spectrometry.Understanding signal transduction through functional proteomics.Mass spectrometry-based peptide quantification: applications and limitations.Charting protein complexes, signaling pathways, and networks in the immune system.Amino acid-coded tagging approaches in quantitative proteomics.Utility of cleavable isotope-coded affinity-tagged reagents for quantification of low-copy proteins induced by methylprednisolone using liquid chromatography/tandem mass spectrometry.Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis.Human saliva proteome analysis and disease biomarker discovery.Cysteine tagging for MS-based proteomics.Nano-enabled biomarker discovery and detection.Nutriproteomics: technologies and applications for identification and quantification of biomarkers and ingredients.Systems biology analysis of protein-drug interactions.The emerging field of chemo- and pharmacoproteomics.Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution.Quantitative proteomics using SILAC: Principles, applications, and developments.Affinity purification in target identification: the specificity challenge.Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.The evolving role of infectomics in drug discovery.Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards.
P2860
Q26786427-FFC575C0-0C5D-4822-B87D-9960679F2D76Q28291379-A472F1C1-BB28-4CD4-89DE-F2DBF46AFFDFQ31134606-5A4595EA-0ABD-4517-BC04-37437B054746Q33193265-E85F77D7-9479-4527-9E08-F4898F466ACFQ33236750-C01E1FF8-8CF3-4EC9-99CB-19607F1594ECQ33374168-6773CF3A-2D94-4CC2-B4B8-C94B9A76C765Q33591828-6CFEA22B-2ED4-477B-881F-3A0219EA13E9Q33852378-3FF94B6E-9CCB-494B-ABD0-A571D7D3F4FBQ33999524-DC782170-BC71-4359-ABF9-15D2EAE880ECQ34342900-0B9BBD10-D419-499F-962A-C32342E90ADBQ34589404-867C2EF8-F5D5-444F-A6FC-3E9E372DAAA4Q34600986-8AE0B17B-7995-45F1-9E94-66A92EE760E7Q34626974-AB43207A-D6FB-414D-A8AE-A05D00136F9AQ34784928-24A2622E-2DF4-4CDD-8926-EE50DF8BD275Q35652038-2EE17F9B-30E0-4FAF-90EE-1C41010E2C01Q35828594-A06DF844-05B1-472C-A154-587F75C63A55Q35895904-38896B65-0090-46CD-B801-4E789C7CF3CBQ35973576-321B7911-18A6-4C77-92F8-8AA2ADDBA5A8Q35983937-9FC9E0F8-0EA4-4CAD-8F66-DF947584F873Q35990045-EDFB992D-A663-48E3-BAF7-6083A4AFAD1DQ36168483-6ECBE923-5174-4C96-9312-AE1E2A52A02EQ36184812-DA4AEC75-FB7A-4F6E-9F3D-DC41A2871184Q36453373-F22E7CD0-0C36-439E-AB61-E1BACE7F4F7EQ36731378-29E81BB7-332F-482A-A245-293981794F26Q36837337-7D571734-7BAA-44E3-8C8B-C2152B0CCC93Q36845726-010D38E3-AB7E-426B-A3C7-ACF47C4C12CAQ36913053-F0A2E5F5-A976-4E52-B637-963E82EB6AA6Q37866224-8CBC0D5F-BFCB-4B3C-BD0C-1E280FCD05E2Q37886999-28E47527-893C-4857-A1F6-3C08DAB004EAQ37903978-29AE8BF4-744A-4D22-ADF9-DD6C064574D4Q37972867-1FBD27F2-571B-4CF0-9D5A-034B3C3FCF18Q38062904-DCBD896A-C7FC-4142-B0E3-D2CA6767C17FQ38089202-85A9894B-4C2F-468F-8168-777F32A10B0DQ38533946-3D12A1D6-257D-4BB6-9A8E-0E77A36343E6Q38561919-DCA4CA90-82CB-4898-B7DE-867EE8A38012Q39393574-B066888B-0663-4F99-AD51-FD6162A4F13EQ46023519-2B9B4D22-BB55-4759-9E1D-C145DA835C69Q48336339-48560BDC-B6C7-4A2B-8DFC-0D30B52E3CD0Q48925714-0A6A2965-F3F3-4280-AE5F-EE304470E07B
P2860
Quantitative chemical proteomics for identifying candidate drug targets.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Quantitative chemical proteomics for identifying candidate drug targets.
@en
type
label
Quantitative chemical proteomics for identifying candidate drug targets.
@en
prefLabel
Quantitative chemical proteomics for identifying candidate drug targets.
@en
P2093
P356
P1433
P1476
Quantitative chemical proteomics for identifying candidate drug targets.
@en
P2093
Akira Yokoi
Brian Boucher
Hidenori Yamanaka
Junro Kuromitsu
Scott Daniels
Takashi Owa
Takeshi Nagasu
Toshitaka Sato
Yasuhiro Shinohara
Yoshiya Oda
P304
P356
10.1021/AC026196Y
P407
P577
2003-05-01T00:00:00Z